Filing Details
- Accession Number:
- 0001375151-19-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-08 16:48:23
- Reporting Period:
- 2019-03-06
- Accepted Time:
- 2019-03-08 16:48:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375151 | Zogenix Inc. | ZGNX | Pharmaceutical Preparations (2834) | 205300780 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543174 | P Renee Tannenbaum | C/O Zogenix, Inc. 5959 Horton Street, Suite 500 Emeryville CA 94608 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-06 | 9,375 | $10.40 | 19,375 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-06 | 6,000 | $12.80 | 25,375 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-06 | 20,000 | $12.75 | 45,375 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-06 | 20,000 | $8.99 | 65,375 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-06 | 17,503 | $50.65 | 47,872 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-03-06 | 9,375 | $0.00 | 9,375 | $10.40 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-03-06 | 6,000 | $0.00 | 6,000 | $12.80 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-03-06 | 20,000 | $0.00 | 20,000 | $8.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-03-06 | 20,000 | $0.00 | 20,000 | $12.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-05 | No | 4 | M | Direct | |
| 3,000 | 2025-06-17 | No | 4 | M | Direct | |
| 0 | 2026-07-12 | No | 4 | M | Direct | |
| 0 | 2027-05-22 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $50.40 to $50.90, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option was granted on February 6, 2015, which is the vesting commencement date. Shares subject to the option vests over three years in thirty-six equal monthly installments, subject to the Reporting Person's continued service to the Company on each vesting date.
- The option was granted on June 18, 2015 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
- The option was granted on July 13, 2016 and vests in a series of twelve (12) successive, equal monthly installments, on the first day of each calendar month following the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
- The option was granted on May 23, 2017, the date of the Company's Annual Meeting of Stockholders, and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
Billionaire Hedge Funds
